Investor
Michael Wieser
Individual investor
Key details
- Profile type
- Individual investor
- Geography
- Singapore
- Stage
- 1. Idea or Patent, 2. Prototype, 3. Early Revenue, 4. Scaling, 5. Growth, 6. Pre-IPO
- Sector
- finserv, protein, banking, paytech, cannabis, CBD, gene therapy, medicines, psychedelic, genomics, in vitro diagnostics, life sciences tools, biotech, insuretech, lifesciences, insurance, fin-tech, wealthtech, mRNA, pharmaceuticals, smart building, regtech, subscription, SaaS, lifescience, life sciences, CGT, property, therapeutics, real estate, lending, payment, prop-tech, therapeutic, pharma, connected home, finance, biomarkers, fintech, psychedelics, financial services, bio, prop tech, insur tech, insurtechs, smart home, transcriptomics, recurring, life science, construction, drug, fintechs, proptech, cell therapy, IVD, life-science, metabolomics, proteomics, insurtech, drugs, smarthome, biopharma, metabolites, bank
- Invests in
- ["Canada","Chile","China","Hong Kong","Japan","Malaysia","Singapore","South Korea","Taiwan","Thailand","Austria","Belgium","Estonia","France","Germany","Sweden","Switzerland","UK","Australia","New Zealand"]
- Investment size
- $10k to $100k
- Founder groups
- Not publicly stated
Official source
TorontoStarts does not endorse or rank this record. Confirm current details with the official source.